Determination of therapeutic and toxic concentrations of doxepin and loxapine using gas-liquid chromatography with a nitrogen-sensitive detector, and gas chromatography-mass spectrometry of loxapine.
A gas-liquid chromatographic procedure is presented for the determination of therapeutic and toxic serum levels of doxepin and loxapine, using a nitrogen-phosphorus-sensitive detector. Amitriptyline is used as the internal standard. The method is accurate, sensitive and specific with no derivatization required prior to analysis. An advantage of the procedure is the small serum sample size needed for analysis and the selectivity and sensitivity of the detector, with the limit of detection being 3 and 2 microgram/l for doxepin and loxapine, respectively. Nine cases of doxenin and loxapine misuse are presented. Serum doxepin concentrations ranged from 113 to 439 microgram/l, with a loxapine concentration of 192 microgram/l observed in one patient. The presence of the tricyclics was identified and confirmed by gas chromatography-mass spectrometry and the mass spectrum of loxapine is reported.
D000328:Adult; D002849:Chromatography, Gas / Q000379:methods*; D003989:Dibenzoxazepines / Q000097:blood*; D004316:Doxepin / Q000097:blood* / Q000627:therapeutic use; D008401:Gas Chromatography-Mass Spectrometry / Q000379:methods; D006801:Humans; D008152:Loxapine / Q000097:blood* / Q000627:therapeutic use; D019966:Substance-Related Disorders / Q000097:blood
D003989:Dibenzoxazepines; D004316:Doxepin; D008152:Loxapine